Objective To study the acute and chronic effect of hyperglycemia on perivascular adipose tissue (PVAT) function in rat aorta.
Introduction
In diabetes, the presence of endothelial dysfunction, based on the attenuation of endothelium-dependent relaxation response to acetylcholine, was generally noted. Most of these studies suggested that endothelium was damaged due to the effects of reactive oxygen species (ROS), such as superoxide [1] [2] [3] [4] . Treatments that lowered blood pressure or reduced hyperglycemia [5] [6] [7] [8] [9] or treatment with antioxidants such as vitamin C [10] or tempol [11] usually restored endothelial function.
Recent studies have now highlighted the importance of perivascular adipose tissue (PVAT) in the regulation of vascular functions. PVAT has been shown to release an unknown PVAT-derived relaxation factor(s) (PVRF) in rat aorta [12, 13] , rat mesenteric artery [14] , and human internal thoracic artery [15] . In rat aorta, we have demonstrated that PVAT modulates the relaxation response of blood vessels through an endothelium-dependent mechanism involving nitric oxide release and an endotheliumindependent mechanism involving hydrogen peroxide (H 2 O 2 ) production by PVAT [16] . The modulation of vascular function by PVAT is not limited to the secretion of relaxing factor(s). We have found that PVAT enhanced the contractile response elicited by perivascular nerve activation by electrical field stimulation, and that this enhancement involved the production of superoxide by PVAT mediated by nicotinamide adenine dinulceotide phosphate [NAD(P)H] oxidase, and activation of tyrosine kinase and mitogen-activated protein kinase/extracellular signaling-regulated kinase (MAPK/ERK) pathway [17] . Superoxide released by PVAT also mediates angiotensin II-induced potentiation of contractile response to sympathetic stimulation [18] . Therefore, PVAT shows some similarity to endothelium in its ability to release both relaxation and contraction factors in the regulation of vascular functions.
The relaxation property of PVAT is altered under some pathological conditions. We have shown that the function of aortic PVAT was impaired in obese [19] and hypertensive [20] rats induced by perinatal exposure to nicotine. Lipoatrophic mice, which are born without white adipose tissue, are hypertensive with associated functional changes in the blood vessels [21] , indicating that PVAT indeed plays important physiological/and pathological roles in modulating vascular function. However, it remains unknown whether the function of PVAT is altered in diabetes. Here we studied the acute and chronic effects of hyperglycemia on the modulatory role of PVAT on vascular function.
Materials and methods

Animals
Male Wistar rats 13-14-week old were obtained from Harlan (Indianapolis, Indiana, USA). These rats were used to study the acute effects of hyperglycemia on vascular functions. The chronic effect of hyperglycemia was studied in the streptozotocin (STZ)-induced diabetes model. Under isoflurane anesthesia, STZ in citrate buffer at 70 mg/kg dose was injected into the tail vein of male Sprague-Dawley rats (150-170 g). Rats injected with citrate buffer alone served as controls. Blood samples were obtained after 2 days and at weekly intervals thereafter. Blood glucose levels were measured using a DEX glucometer (Bayer, Elkhart, Indiana, USA), insulin levels were measured by enzyme-linked immunosorbent assay (ELISA; Crystal Chem, Downers Grove, Illinois, USA), and triglyceride levels were determined using a colorimetric assay (Thermo Scientific, Waltham, Massachusetts, USA). Rats were sacrificed 6 weeks after the induction of hyperglycemia and samples of thoracic aorta were taken for functional and morphological studies. This study conformed to the guidelines of the Canadian Council on Animal Care and was approved by the Animal Research Ethics Board of McMaster University.
Contractility and relaxation study
The procedure for the preparation of aortic rings has been described in our previous report [19] . Briefly, the rat was euthanized with an overdose of sodium pentobarbital [60 mg/kg, intraperitoneally ( i.p.)] and the aorta was collected in oxygenated physiological salt solution (PSS) with the following composition (in mmol/l): NaCl, 119; KCl, 4.7; KH 2 PO 4 , 1.2; MgSO 4 , 1.2; NaHCO 3 , 25; CaCl 2 , 1.6; glucose, 11, at 48C. Paired aortic rings with or without PVAT (PVATþ and PVATÀ, 4 mm long for each) were prepared with either intact endothelium (Eþ) or with endothelium removed (EÀ) using the middle segment of the thoracic aorta. PVAT removal was carried out with fine scissors under a dissection microscope. Caution was taken not to damage the adventitial layer during the dissection. Endothelium was removed by gently rubbing the internal surface with a fine wooden stick, and successful removal of endothelium was confirmed by the absence of a relaxation response to carbamylcholine (CCh, 1 mmol/l) in rings precontracted with phenylephrine (PHE, 1 mmol/l). A computerized myograph system was used to record the isometric tension of the aortic rings. After equilibration at 378C for at least 90 min at 3 g of preload, which is the optimal preload defined in our previous experiment [19] , the arterial rings were challenged with 60 mmol/l KCl twice at an interval of 30 min. Concentration-related contractile response curves to PHE were constructed and these responses were expressed as a percentage of KCl contraction. These vessels were then incubated with 22 mmol/l D-glucose for 30 min and concentration-related contractile response curves to PHE were again constructed. Vessels incubated with 22 mmol/l L-glucose served as controls. In vessels with or without PVAT, the effect of incubation with nitric oxide synthase inhibitor N v -nitro-L-arginine (L-NNA) or nitric oxide scavenger carboxy-2-phenyl-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide (carboxy-PTIO) on the contractile response of the vessels to PHE was studied. The effect of incubation with 22 mmol/l D-glucose on the relaxation response to CCh was also studied in vessels precontracted with PHE (1 mmol/l).
To study the acute effect of hyperglycemia on the diffusible component of PVRF, solutions from aorta with intact PVAT incubated with 22 mmol/l D-glucose (donor) were transferred to organ chambers containing aorta with PVAT removed (recipient), to determine the relaxation property of donor solution on vessels precontracted with PHE (1 mmol/l). The recipient chamber also contained 22 mmol/l D-glucose. Vessels incubated with 22 mmol/l L-glucose were used as controls. Thoracic aortae from rats treated with STZ or buffer were taken and contractile response of these vessels in response to PHE or serotonin, or relaxation response of these vessels precontracted with PHE (1 mmol/l) to CCh was studied. In vessels with or without PVAT, the effect of incubation with nitric oxide synthase inhibitor L-NNA or nitric oxide scavenger carboxy-PTIO on the contractile response of the vessels to PHE was studied.
Morphometric measurement of aorta and perivascular adipose tissue Samples of thoracic aorta from STZ and control rats were fixed in 10% buffered formalin and embedded in paraffin. Five-micron thick cross-sections of the arteries were stained with hematoxylin and eosin. Morphometric measurement of vascular wall dimensions and the size of PVAT and adipocytes were measured using an Olympus microscope equipped with Image-Pro Plus morphometric measurement system (Olympus Canada, Markham, Ontario, Canada).
Statistical analyses
Results were expressed as mean AE SE, where n represents the number of rats. Statistical analysis was performed by two-way repeated measurements or oneway analysis of variance followed by post hoc t-test to determine concentration-dependent effects, or by Student's t-test to test treatment effects, using the SPSS software (SPSS Inc., Chicago, Illinois, USA). The differences were considered significant when P was 0.05 or less.
Results
Physical characteristics
Body weight of rats treated with STZ was similar to control rats. Heart weight was lower in STZ rats than controls, whereas kidney weight was higher in STZ than control (Table 1 ). There was no significant difference in dry-to-wet weight ratio of the kidneys between STZ and control rats, indicating the absence of tissue edema (Table 1) . Plasma level of random glucose averaged 6.0 mmol/l before STZ injection. This level was Comparison between control and vessels incubated with 22 mmol/l D-glucose for 30 min in vessels with intact perivascular adipose tissue (PVATþ). Aorta incubated with glucose contracted less both in the presence (a) and absence (b) of endothelium (E). In vessels with PVAT removed, incubation with D-glucose had no effect on phenylephrine (PHE)-induced contraction (c and d). Ã P < 0.05, ÃÃ P < 0.01, n ¼ 8 rats in each group. increased to more than 20 mmol/l 1 week after injection and maintained at this high level 6 weeks after the injection (Table 1) . Plasma levels of triglyceride and cholesterol were also increased in STZ rats than controls (Table 1) . Plasma insulin level was decreased in STZ rats (0.06 ng/ml) as compared with controls (1.67 ng/ml).
Vessel wall dimensions
Lumen diameter of thoracic aorta was similar between STZ and control rats (Table 1) . Medial thickness and cross-sectional area of PVAT were smaller in STZ rats as compared with controls. Cross-sectional area of PVAT surrounding the aorta and average size of adipocytes were smaller in the STZ rats than control rats (Table 1) .
Contractile and relaxation response of aorta from normal Wistar rats KCl-induced contraction was similar among aorta with intact PVAT and E, and vessels with either PVAT or E, or both removed (data not shown). In aorta with intact PVAT and E, incubation with 22 mmol/l D-glucose caused an attenuation of concentration-dependent contraction in response to PHE (Fig. 1a) . This attenuation effect was also present in vessels with E removed (Fig. 1b) , but not in vessels with PVAT removed (Fig. 1c and d) . Incubation with 22 mmol/l L-glucose had no effect on the contractile response of the vessels to PHE (data not shown), showing that the effect observed with D-glucose was not due to osmotic effect. Incubation of the aorta with 22 mmol/l D-glucose for 30 min did not affect the relaxation property of the vessel in response to CCh (data not shown).
In aorta with intact PVAT and E, incubation of the vessels with nitric oxide synthase inhibitor L-NNA (0.1 mmol/l, Fig. 2a potentiation effect was more pronounced after incubation of the vessels with 22 mmol/l D-glucose for 30 min (Fig. 2c  and d) . Such a further potentiation of contraction effect was not observed when vessels were incubated with 22 mmol/l L-glucose (data not shown), showing that the effect observed with D-glucose was not due to osmotic effect. In vessels with PVAT removed, incubation with L-NNA or carboxy-PTIO caused a small potentiation of contraction in response to PHE, but incubation with D-glucose did not show the further potentiation effect (Fig. 3 ) seen with vessels with intact PVAT. Incubation with L-glucose also did not increase the potentiation effect of contraction to PHE in PVAT denuded vessels (data now shown). In vessels denuded of endothelium but with intact PVAT, incubation with catalase (1000 U/ml) for 30 min caused a slight potentiation of contraction to PHE (Fig. 4a) and this effect was not changed by incubation with D-glucose (Fig. 4c) . In contrast, incubation with superoxide dismutase (SOD, 150 U/ml) for 30 min reduced the contractile response of the aorta to PHE (Fig. 4b) , and incubation with D-glucose showed a similar reduction in contraction to PHE (Fig. 4d) . Similar results were obtained with L-glucose (data not shown). Removal of PVAT eliminated the effects seen with catalase or SOD in vessels treated with either D-glucose or L-glucose (data not shown).
Contractile and relaxation response of aorta from streptozotocin rats In aorta from STZ and control rats, contractile response of the vessel to KCl was similar among the vessels with or without PVAT or E (data not shown). The presence of PVAT did not affect concentration-related relaxation response of the aorta to CCh in both STZ and control rats (data not shown). There was also no difference in the relaxation response of the aorta to CCh between STZ and control rats. Concentration-related contractile response of aorta to PHE in both STZ and control rats showed the highest response in PVAT-EÀ vessels and the lowest response in PVATþEþ vessels, with vessels denuded of either PVAT or E showing similar response (Fig. 5) . In aorta from control rats with intact E, the presence of PVAT caused a 14% attenuation of the contraction to PHE (Fig. 6a) , as compared with 28% in STZ rats (Fig. 6b) . In aorta with E removed, the presence of PVAT caused a similar attenuation of contraction (16%) in the control (Fig. 6c) as compared with 24% in STZ rats (Fig. 6d) . Concentration-dependent contractile response of the aorta to serotonin also showed a similar trend as with PHE, with PVAT-EÀ showing the highest response and PVATþEþ vessels showing the lowest response, while vessels with either PVAT or E removed showing similar response (Fig. 7) . The presence of PVAT caused a similar attenuation of contractile response of the aorta to serotonin between STZ and control rats in vessels both with or without E (Fig. 8) . Transfer of incubating solution from aorta with intact PVAT to vessel with PVAT removed caused a similar relaxation response in aorta precontracted with PHE in STZ and control rats (data not shown). Cross-transfer of solution incubated with control donor to STZ recipient vessel, or from STZ donor to control vessel caused a similar relaxation response (data not shown).
Preincubation of the aorta from control rats with either L-NNA or carboxy-PTIO potentiated the contraction of the vessels to PHE, and this potentiation effect was higher in the vessels from STZ rats than control rats when L-NNA was used but not with carboxy-PTIO (Fig. 9) . Removal of PVAT reduced this potentiation effect and there was no difference between vessels from control and STZ rats (Fig. 10) . In vessels with endothelium removed, incubation with catalase showed a similar potentiation of contraction to PHE in vessels from both control and STZ rats (Fig. 11a, c) . In contrast, incubation with SOD attenuated the contraction to PHE but there was no difference between vessels from control and STZ rats (Fig. 11b, d) . Removal of PVAT eliminated In vessels denuded of endothelium but with intact perivascular adipose tissue (PVAT), incubation with catalase (1000 U/ml) for 30 min caused a slight potentiation of contraction to phenylephrine [PHE; (a)] and this effect was not changed by incubation with D-glucose (c). In contrast, incubation with superoxide dismutase (SOD, 150 U/ml) for 30 min reduced the contractile response of the aorta to PHE (b), and incubation with D-glucose did not change this attenuation effect (d). n ¼ 5 rats in each group. the effects seen with either catalase or SOD (data not shown).
Discussion
The main findings in this study are that under both acute and chronic conditions, hyperglycemia enhanced the relaxation response of the aorta modulated by the relaxation factors from PVAT. Endothelium-mediated relaxation property in response to CCh was not affected by hyperglycemia. We suggest that these new results on the modulation of vascular function by PVAT under the influence of hyperglycemia provide important information regarding the mechanism underlying the postprandial effect of hyperglycemia on blood pressure control, and also the presence of hypotension under chronic hyperglycemic condition in a type-1 model of diabetes.
Postprandial hypotension is a prevalent condition in the elderly population and seems to be more common in frail elderly individuals who may exhibit abnormal sympathetic function or baroreceptor function, but the precise relationship between symptoms and postprandial reductions in blood pressure is unclear [22] . In patients with autonomic failure who have severe sympathetic impairment, food substantially lowers blood pressure even in the supine position [23] . This is related to a marked increase in splanchnic blood flow, without compensatory changes in the rest of the circulation. Of the Concentration-related response curves of aorta from control rats (a) and streptozotocin (STZ) rats (b) to phenylephrine (PHE), in vessels with (þ) or without (À) perivascular adipose tissue (PVAT) or endothelium (E). Vessels with PVAT and E removed showed the most contractile response, whereas vessels with intact PVAT and E were least responsive to PHE. Ã P < 0.05, ÃÃ P < 0.01, n ¼ 8 rats in each group. food components, glucose causes similar effects of food, whereas an isosmotic, isocaloric load of the inert carbohydrate, xylose, causes only a small fall in blood pressure [23] . Our finding that acute exposure of blood vessels to high glucose solution potentiated the relaxation property of the blood vessels modulated by PVAT provides an additional mechanism regarding postprandial effects of food (or glucose) on blood pressure regulation.
In the STZ model, injection of STZ destroys the insulin secreting b-cells of the pancreas and these rats develop severe chronic hyperglycemia analogous to type 1 (insulin-dependent) diabetes mellitus [24] . In contrast with other models, blood pressure in these rats is reduced beginning at 2 weeks after injection [25] . Response of mesenteric vascular bed to agonists was reduced in STZ rats as compared with controls and maximum relaxation response to acetylcholine was also reduced [25] . In this study, we found that both in the presence and absence of endothelium, the presence of PVAT caused an attenuation of contractile response to PHE in both control and STZ rats, indicating that relaxation factors released from PVAT which act through an endothelium-dependent and endothelium-independent mechanisms were still present in these rats. However, in aorta with intact endothelium, the attenuation of the contraction effect of PVAT in response to PHE was more in STZ rats than control, but such a difference was not observed when serotonin was used as the agonist. These results suggest that alteration of modulating function of PVAT due to hyperglycemia is specific to the type of agonists used. Nevertheless, our results showed that chronic hyperglycemia in this model caused a potentiation of the relaxation response modulated by PVAT in Eþ vessel in response to PHE, the most common agonist for blood vessels. In addition, heart-to-body weight ratio was lower in STZ rats than controls. These results provide several plausible explanations on the presence of hypotension in this diabetic model. It remains to be determined whether modulatory function of PVAT in resistance arteries is altered under chronic hyperglycemia.
One result from our study that may provide another explanation for the presence of hypotension in this In the presence of endothelium (Eþ), the presence of perivascular adipose tissue (PVATþ) attenuated the contraction to phenylephrine (PHE) by 14% in aorta from control (a) as compared with 28% in streptozotocin (STZ) rats [(b), P ¼ 0.05]. After removal of the endothelium, the presence of PVAT caused a 16% attenuation of contraction to PHE in the control vessels (c) as compared with 24% in vessels from STZ rats [(d), P ¼ 0.08]. n ¼ 8 rats in each group.
model is the presence of reduced PVAT mass and reduced thickness of the aorta. A reduced medial mass will reduce the contractile ability of the vessels in response to agonists. Study of resistance arteries in this model will help to clarify this issue. A reduced amount of PVAT may be due to the low level of insulin, reducing the ability of the PVAT to utilize glucose to produce more fat tissue. Whether such a reduction in the amount of PVAT is sufficient to affect overall response of a vascular bed remains to be studied. Results to date showed that there is not a positive correlation of PVAT mass and PVAT function. In rats treated with nicotine perinatally, some of them became obese [19] or hypertensive [20] . An increase in PVAT mass was found in some rats [19] and not in others [20] , but PVAT function to attenuate contraction was reduced in these rats. In the spontaneously hypertensive rats, PVAT mass and adipocyte size were decreased and PVAT function to attenuate contraction was reduced [26] . Here we found that a reduced PVAT mass was actually associated with a potentiation effect of PVAT function change. As changes in adipocyte size (thus PVAT mass) are associated with lipid accumulation property of adipocytes in response to metabolic need, it is possible that any change in this property, which affects PVAT mass, is not associated with changes in the function of PVAT in its regulation of vascular functions. Concentration-related response curves of aorta from control rats (a) and streptozotocin (STZ) rats (b) to serotonin (5-HT), in vessels with (þ) or without (À) perivascular adipose tissue (PVAT) or endothelium (E), showing in both groups that vessels with PVAT and E removed had the most contractile response, whereas vessels with intact PVAT and E were least responsive to 5-HT. Ã P < 0.05, ÃÃ P < 0.01, n ¼ 8 rats in each group.
In our previous study of aorta from Wistar rats, we have found that the order of contraction induced by PHE or serotonin was PVATþEþ < PVATþEÀ ¼ PVATÀEþ < PVATÀEÀ [16] . This was because in PVATþEþ aorta, the attenuation of contraction was exerted by a combined effect of relaxation factors released by PVAT and E, so that PVATþEþ aorta contracted the least. Removal of PVAT or E had a similar effect in attenuating the relaxation response of the aorta because of the removal of the relaxation factor from PVAT or E, whereas removal of PVAT and E eliminated the influence of the relaxation factors from these two sources, so that such a vessel showed the most contraction [16] . In our acute experiments, we found that incubation of aorta with 22 mmol/l of D-glucose for 30 min was sufficient to attenuate the contractile response induced by PHE both in the presence and absence of endothelium. This effect was not observed in vessels with PVAT removed or in vessels incubated with L-glucose. This is significant because in previous studies on the glucose effect, there was a discrepancy between in-vivo observations, and also between in-vivo and in-vitro observations. In normal humans, some earlier studies [27, 28] have reported that acute hyperglycemia reduced endothelium-dependent relaxation response. However, uncomplicated type 1 diabetes mellitus is characterized by generalized vasodilatation, and acute hyperglycemia and/or hyperinsulinemia were found to enhance vasodilatation in these patients [29] . In healthy humans, acute hyperglycemia did not affect endothelium-dependent vasodilator response to acetylcholine [30] . In contrast, in in-vitro studies, long incubation time was required to see the detrimental effects of hyperglycemia on endothelium function, ranging from 2-3 h [31] [32] [33] [36] . The main difference was that in in-vivo studies, PVAT was intact, whereas in in-vitro studies, PVAT was removed, therefore eliminating the modulating effects of PVAT. Long incubation time used in in-vitro studies would have a deleterious effect on endothelial functions. Our observation that 30 min incubation with high glucose solution attenuated the contraction induced by PHE can be explained by the release of nitric oxide by E in response to acute hyperglycemia, which was reported in porcine coronary artery [37] . In the presence of PVAT, the release Effects of hyperglycemia on modulation of vascular function Lee et al. 127 of nitric oxide stimulated by the transferable relaxation factor from PVAT is in addition to the nitric oxide produced by endothelium in response to glucose, so that more attenuation of contraction by PHE is found. The involvement of nitric oxide is supported by our observations that nitric oxide synthase inhibitor L-NNA and nitric oxide scavenger carboxy-PTIO significantly affected this process. In both instances, in aorta with intact PVAT, incubation with either L-NNA or carboxy-PTIO potentiated the contractile response of the aorta to PHE, showing that the release of nitric oxide was involved. Removal of PVAT or incubation with L-glucose also removed the potentiation effect seen with D-glucose, thereby showing that this response was specific to this relaxation factor released by PVAT and that hyperglycemia potentiated the effect of this relaxation factor through the release of nitric oxide by the endothelium.
In our previous study [16] , we have found that one of the relaxation factors released by PVAT acts through an endothelium-independent mechanism involving H 2 O 2 produced from superoxide. Here we found that in EÀ vessels, preincubation with catalase that catabolizes H 2 O 2 potentiated PHE-induced contraction and D-glucose did not increase this potentiation effect. Similarly, preincubation with SOD, which converts superoxide to H 2 O 2, caused an attenuation of contraction to PHE and incubation with D-glucose did not cause a further increase in this attenuation effect. These results showed that an alteration in the modulation of vascular function by PVAT due to acute exposure to hyperglycemia did not involve an endothelium-independent pathway.
Transfer of solution incubated with PVATþ vessels to PVATÀ recipient vessel caused a relaxation response in both control and STZ aortae, indicating that the diffusible relaxation factor released by PVAT was still present and functional in PVAT from these rats. Cross-transfer of donor solutions between control and STZ rats showed that similar relaxation response was found in the recipient Incubation of the aorta from control rats with either N v -nitro-L-arginine (L-NNA) or carboxy-2-phenyl-4,4,5,5-tetra-methyl-imidazoline-1-oxyl-3-oxide (carboxy-PTIO) potentiated the contraction of the vessels to phenylephrine [PHE; (a, b)] and this potentiation effect was higher in the vessels from streptozotocin (STZ) rats than control rats when L-NNA was used (P < 0.05) but not with carboxy-PTIO (P ¼ 0.12). n ¼ 5 rats in each group. vessels, indicating that relaxation response of the vessels to the factors released by PVAT was not altered in STZ rat vessels. However, functional studies involving the use of nitric oxide synthase inhibitor showed that under chronic hyperglycemic condition (i.e. in STZ rats), the effect of the relaxation factor that acts through the release of nitric oxide by the endothelium was also increased. This is consistent with our results from acute hyperglycemia study. We also found that the endothelium-independent action of the relaxation factors from PVAT was not altered in STZ rats, because after removal of endothelium, the potentiation effect of PVAT was similar between control and STZ rats. Furthermore, in EÀ vessels, preincubation with catalase or SOD had a similar effect on vessels from control and STZ rats. These results showed that chronic exposure to hyperglycemia did not affect the PVAT modulation effect that operates through the endothelium-independent pathway, which are in general agreement with the results we have obtained on the acute effects of hyperglycemia.
In conclusion, we have shown that acute and chronic hyperglycemia caused a potentiation of the relaxation response modulated by PVAT in the blood vessels mediated by endothelium. These results indicate that PVAT plays an important role in modulating vascular functions under hyperglycemic conditions. We suggest that this modulating effect probably contributes to the presence of postprandial hypotension in some elderly patients and hypotension in a type-one model of diabetes. Further studies are needed using other animal and human models to confirm our observation on the effects of hyperglycemia on PVAT-modulated vascular functions. In vessels with endothelium removed, incubation with catalase showed a similar potentiation of contraction to phenylephrine (PHE) in vessels from both control and streptozotocin (STZ) rats (a, c). Similarly, incubation with superoxide dismutase (SOD) attenuated the contraction to PHE in vessels from control and STZ rats (b, d). n ¼ 5 rats in each group.
